Long-term use of proton pump inhibitors may cause an increased risk of falls and fractures.
Many options are available for patients experiencing symptomatic or bothersome manifestations.
Polycystic ovarian syndrome, which is a complex disease, is the most common endocrine disorder affecting females of reproductive age.
Hormone replacement therapy is a key element of managing the symptoms experienced by menopausal women.
The FDA recently approved the first agent for treatment of hypoactive sexual desire disorder.
Routine screening helps identify the disease in its early stages.